|
Market Closed -
Other stock markets
|
After market 16:20:00 | |||
| 1,006 DKK | +0.30% |
|
1,005 | -0.08% |
| 12:42pm | India plans incentives for diabetes, obesity drug makers in 2026, government official says | RE |
| 09:22am | NOVO NORDISK : UBS gives a Neutral rating | ZD |
NOVO NORDISK SEMAGLUTIDE APPROVED FOR LONG-TERM WEIGHT MANAGEMENT IN CHINA - COMPANY STATEMENT
| 1st Jan change | Capi. | |
|---|---|---|
| +44.05% | 638B | |
| +56.76% | 819B | |
| -6.59% | 351B | |
| +19.12% | 329B | |
| +9.30% | 298B | |
| +16.75% | 242B | |
| +2.13% | 225B | |
| +13.18% | 217B | |
| +8.94% | 168B | |
| -2.95% | 158B |
NOVO NORDISK A/S 
